Phase 2, Double-Blind, Placebo-Controlled Study of Oral Dimebon [dimebolin] in Subjects With Mild to Moderate Alzheimer's Disease

Trial Profile

Phase 2, Double-Blind, Placebo-Controlled Study of Oral Dimebon [dimebolin] in Subjects With Mild to Moderate Alzheimer's Disease

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Nov 2015

At a glance

  • Drugs Latrepirdine (Primary)
  • Indications Alzheimer's disease
  • Focus Registrational; Therapeutic Use
  • Sponsors Medivation
  • Most Recent Events

    • 10 Feb 2010 Endpoint methodology added (where possible).
    • 09 Sep 2008 Primary efficacy results from the open-label extension phase presented at ADRD in July 2008
    • 26 Jul 2008 Primary endpoint results presenetd at ADRD in July 2008
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top